Related Experiment Videos
Serum AGE-elastin derived peptides among diabetic children
G Nicoloff1, A Nikolov, D Dekov
1Department of Biology and Pathological Physiology, University School of Medicine, 1, St. Kliment Ohridski Street, 5800 Pleven, Bulgaria. nicoloff_bg@yahoo.com
Vascular Pharmacology
|October 26, 2005
Summary
This study measured advanced glycated end products (AGE) of elastin in diabetic children, finding higher levels in those with vascular complications. These AGE-elastin-derived peptides (AGE-EDP) may serve as markers for diabetic vascular disease.
Area of Science:
- Biochemistry
- Endocrinology
- Vascular Biology
Background:
- Advanced glycated end products (AGE) are implicated in diabetic complications.
- Elastin degradation products are potential biomarkers for vascular damage.
Purpose of the Study:
- To adapt and validate an ELISA technique for quantifying AGE-elastin-derived peptides (AGE-EDP) in human serum.
- To investigate the association between serum AGE-EDP levels and vascular complications in Type 1 diabetic children.
Main Methods:
- An ELISA assay was developed using alpha-elastin and AGE-Hemocyanin.
- Polyclonal antibodies against AGE-Hemocyanin and alpha-elastin were generated and validated.
- Serum samples from 60 Type 1 diabetic children and 28 healthy controls were analyzed for AGE-EDP.
Main Results:
- Patients with vascular complications exhibited significantly higher AGE-EDP levels compared to those without.
- AGE-EDP concentrations correlated with triglycerides, diastolic blood pressure, and microalbuminuria in diabetic subgroups.
- Specific correlations were observed between AGE-EDP, elastin degradation peptides (EDP), and vascular parameters in patients with microalbuminuria and retinopathy.
Conclusions:
- Serum AGE-EDP levels are elevated in Type 1 diabetic children with vascular complications.
- AGE-EDP may serve as a non-invasive biomarker for monitoring diabetic vascular complications.
- Further research is warranted to elucidate the role of AGE-elastin degradation products in diabetic vascular disease progression and therapeutic interventions.